share_log

Cooper Companies | 8-K: CooperCompanies Announces Fourth Quarter and Full Year 2024 Results

Cooper Companies | 8-K: CooperCompanies Announces Fourth Quarter and Full Year 2024 Results

库珀医疗 | 8-K:CooperCompanies公布2024年第四季度和全年业绩
美股SEC公告 ·  12/06 05:25

Moomoo AI 已提取核心信息

Cooper Companies announced strong financial results for Q4 and full year 2024. Q4 revenue rose 10% to $1,018.4 million, with organic growth of 7%. Full year revenue increased 8% to $3.9 billion. Q4 GAAP EPS grew 38% to $0.58, while non-GAAP EPS rose 19% to $1.04.CooperVision revenue grew 9% to $676.4 million in Q4, with 8% organic growth. CooperSurgical revenue increased 12% to $342.0 million, with 5% organic growth. Gross margin improved to 67% in Q4. The company generated $268.1 million in cash from operations and $128.2 million in free cash flow during the quarter.For fiscal 2025, Cooper projects revenue of $4,080-$4,158 million, representing 6-8% organic growth. Non-GAAP EPS is expected to be $3.92-$4.02. Management expressed confidence in continued success for fiscal 2025.
Cooper Companies announced strong financial results for Q4 and full year 2024. Q4 revenue rose 10% to $1,018.4 million, with organic growth of 7%. Full year revenue increased 8% to $3.9 billion. Q4 GAAP EPS grew 38% to $0.58, while non-GAAP EPS rose 19% to $1.04.CooperVision revenue grew 9% to $676.4 million in Q4, with 8% organic growth. CooperSurgical revenue increased 12% to $342.0 million, with 5% organic growth. Gross margin improved to 67% in Q4. The company generated $268.1 million in cash from operations and $128.2 million in free cash flow during the quarter.For fiscal 2025, Cooper projects revenue of $4,080-$4,158 million, representing 6-8% organic growth. Non-GAAP EPS is expected to be $3.92-$4.02. Management expressed confidence in continued success for fiscal 2025.
库珀医疗公布了2024财年第四季度及全年强劲的财务业绩。第四季度营业收入增长了10%,达到$101840万,且有7%的有机增长。全年营业收入增加了8%,达到了$39亿。第四季度GAAP每股收益增长了38%,达到$0.58,非GAAP每股收益增长19%,达到$1.04。库珀视觉在第四季度的营业收入增长了9%,达到$67640万,8%的有机增长。库珀外科的营业收入增加了12%,达到$34200万,增长了5%的有机增幅。第四季度毛利率提升至67%。公司在本季度内产生了$26810万的运营现金流和$12820万的自由现金流。对2025财年,库珀预计营业收入在$4080-$415800万之间,代表6-8%的有机增长。非GAAP每股收益预计在$3.92-$4.02之间。管理层对2025财年的持续成功表示信恳智能。
库珀医疗公布了2024财年第四季度及全年强劲的财务业绩。第四季度营业收入增长了10%,达到$101840万,且有7%的有机增长。全年营业收入增加了8%,达到了$39亿。第四季度GAAP每股收益增长了38%,达到$0.58,非GAAP每股收益增长19%,达到$1.04。库珀视觉在第四季度的营业收入增长了9%,达到$67640万,8%的有机增长。库珀外科的营业收入增加了12%,达到$34200万,增长了5%的有机增幅。第四季度毛利率提升至67%。公司在本季度内产生了$26810万的运营现金流和$12820万的自由现金流。对2025财年,库珀预计营业收入在$4080-$415800万之间,代表6-8%的有机增长。非GAAP每股收益预计在$3.92-$4.02之间。管理层对2025财年的持续成功表示信恳智能。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息